Cosciens Biopharma Inc
(CSCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-1993 | 08-1993 | 05-1993 | 02-1993 | 11-1992 | |
| Gross Profit | 228 | -332 | 610 | 395 | 228 |
| Operating Expenses | 160 | 65 | 66 | 410 | 160 |
| Operating Income | -160 | -65 | -66 | -410 | -160 |
| Pre-tax Income | -160 | -65 | -66 | -410 | -160 |
| Net Income Continuous | -160 | -65 | -66 | -410 | -160 |
| Net Income | $-160 | $-65 | $-66 | $-410 | $-160 |
| EBITDA(a) | $-160 | $-65 | $-66 | $-410 | $-160 |